Structural and biophysical insights into the mode of covalent binding of rationally designed potent BMX inhibitors
Literature Information
João D. Seixas, Marta C. Marques, Ana Guerreiro, Rui Traquete, Tiago Rodrigues, Inês S. Albuquerque, Di Wu, Shelby K. Doyle, Carol V. Robinson, Angela N. Koehler, Francisco Corzana
The bone marrow tyrosine kinase in chromosome X (BMX) is pursued as a drug target because of its role in various pathophysiological processes. We designed BMX covalent inhibitors with single-digit nanomolar potency with unexploited topological pharmacophore patterns. Importantly, we reveal the first X-ray crystal structure of covalently inhibited BMX at Cys496, which displays key interactions with Lys445, responsible for hampering ATP catalysis and the DFG-out-like motif, typical of an inactive conformation. Molecular dynamic simulations also showed this interaction for two ligand/BMX complexes. Kinome selectivity profiling showed that the most potent compound is the strongest binder, displays intracellular target engagement in BMX-transfected cells with two-digit nanomolar inhibitory potency, and leads to BMX degradation PC3 in cells. The new inhibitors displayed anti-proliferative effects in androgen-receptor positive prostate cancer cells that where further increased when combined with known inhibitors of related signaling pathways, such as PI3K, AKT and Androgen Receptor. We expect these findings to guide development of new selective BMX therapeutic approaches.
Recommended Journals

Science Progress

Molecular Pharmacology

Proceedings of the National Academy of Sciences of the United States of America

Helvetica Chimica Acta

Fibre Chemistry

Nature

Israel Journal of Chemistry

Russian Chemical Reviews

Organic Preparations and Procedures International

Journal of Physics and Chemistry of Solids
Related Literature
Metal-free spin and spin-gapless semiconducting heterobilayers: monolayer boron carbonitrides on hexagonal boron nitride
Hongyu Zhang, Yuanyuan Sun, Yingchun Ding, Jie Chen, Youwei Du, Nujiang Tang
DOI: 10.1039/C7CP01088E
Increased substrate affinity in the Escherichia coli L28R dihydrofolate reductase mutant causes trimethoprim resistance
Haleh Abdizadeh, Yusuf Talha Tamer, Omer Acar, Erdal Toprak, Ali Rana Atilgan, Canan Atilgan
DOI: 10.1039/C7CP01458A
Editorial of the PCCP themed issue on “Physical Chemistry for Life Sciences”
Christoph van Wüllen, Kirsten Schwing, Christoph Riehn, Markus Gerhards
DOI: 10.1039/C7CP90069D
On exo-cyclic aromaticity
Tamal Goswami, Manoswita Homray, Satadal Paul, Debojit Bhattacharya, Anirban Misra
DOI: 10.1039/C7CP02031G
Structural control of side-chain chromophores to achieve highly efficient electro-optic activity
Zhuo Chen, Jialei Liu, Hongyan Xiao, Zhen Zhen, Xinhou Liu
DOI: 10.1039/C7CP01582H
Electrode potential dependent desolvation and resolvation of germanium(100) in contact with aqueous perchlorate electrolytes
Fang Niu, Rainer Schulz, Arcesio Castañeda Medina, Rochus Schmid
DOI: 10.1039/C6CP08908A
A nematic to nematic transformation exhibited by a rod-like liquid crystal
Richard J. Mandle, S. J. Cowling, J. W. Goodby
DOI: 10.1039/C7CP00456G
The role of sulfur oxidation in controlling the electronic properties of sulfur-containing host molecules for phosphorescent organic light-emitting diodes
DOI: 10.1039/C7CP00828G
Investigating the optical properties of BOIMPY dyes using ab initio tools
Boris Le Guennic, Giovanni Scalmani, Michael J. Frisch, Adèle D. Laurent
DOI: 10.1039/C7CP01190C
Visualization of structural evolution and phase distribution of a lithium vanadium oxide (Li1.1V3O8) electrode via an operando and in situ energy dispersive X-ray diffraction technique
Qing Zhang, Andrea M. Bruck, David C. Bock, Jing Li, Varun Sarbada, Eric A. Stach
DOI: 10.1039/C7CP02239E
You might also like
How should waste containing N-Methoxy-N-methyl-1,3-thiazole-5-carboxamide (CAS: 898825-89-3) be handled?
Waste containing N-Methoxy-N-methyl-1,3-thiazole-5-carboxamide (CAS: 898825-89-3...
How should N-(4-Biphenylyl)dibenzo[b,d]furan-4-amine (CAS: 1318338-47-4) be stored?
N-(4-Biphenylyl)dibenzo[b,d]furan-4-amine should be stored in a tightly sealed c...
What is the market or research trend for 3-Acetamido-5-amino-2,4,6-triiodobenzoic acid (CAS: 1713-07-1)?
The market for 3-Acetamido-5-amino-2,4,6-triiodobenzoic acid (CAS: 1713-07-1) is...
How should Benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-beta-D-galactopyranoside (CAS: 61820-03-9) be stored?
Benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-beta-D-galactopyranoside (CAS: 61820-03-9) ...
What regulatory guidelines apply to 2-Ethylpiperazine dihydrochloride (CAS: 438050-52-3)?
2-Ethylpiperazine dihydrochloride (CAS: 438050-52-3) is regulated under the Glob...
What regulatory guidelines apply to 1,1'-[1,3-Phenylenebis(methylene)]bis(3-methyl-1H-pyrrole-2,5-dione) (CAS: 119462-56-5)?
1,1'-[1,3-Phenylenebis(methylene)]bis(3-methyl-1H-pyrrole-2,5-dione) (CAS: 11946...
Are there alternatives to 5-Fluoro-2-(1-pyrrolidinyl)pyridine (CAS: 1287217-79-1) in synthesis?
Several alternatives can be used in the synthesis of 5-Fluoro-2-(1-pyrrolidinyl)...
What precautions should be taken when handling 1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione (CAS: 153631-19-7)?
Proper personal protective equipment (PPE) must be worn when handling this compo...
What precautions should be taken when handling 6-Bromoimidazo[1,2-a]pyridin-8-amine (CAS: 676371-00-9)?
When handling 6-Bromoimidazo[1,2-a]pyridin-8-amine, it is important to wear appr...
Are there alternatives to (2S,4R)-4-(4-Nitrobenzyl)pyrrolidine-2-carboxylic acid hydrochloride (CAS: 1049740-22-8) in synthesis?
Alternatives to (2S,4R)-4-(4-Nitrobenzyl)pyrrolidine-2-carboxylic acid hydrochlo...





